|    Join     |    Donate    |   Store    |   About NAMS
Facebook TwitterYouTubeLinkedinRSS

Video Series-2017

The North American Menopause Society (NAMS) is proud of its comprehensive video series for clinicians about important midlife health topics. All the interviews in the series are hosted by NAMS Board of Trustees Member and Immediate Past President Dr. Marla Shapiro, a Canadian physician, who led this exciting initiative. Dr. Shapiro is also the medical consultant for CTV News.

In this latest video, Prasterone, Dr. Shapiro interviews Dr. Gloria A. Richard-Davis, NAMS Board Member, Division Director of Reproductive Endocrinology and Infertility at the University of Arkansas Medical Sciences and Medical Director of the Physician Assistant Program in Little Rock. Dr. Richard-Davis discusses the new FDA-approved, nonestrogen dehydroepiandrosterone (DHEA) product, prasterone—what it is and what it does to help alleviate pain during sexual intercourse. She also reviews who may be potential candidates for this treatment option, as well as the limited adverse effects.

Additional videos will be posted monthly.

A companion video for your patients is also available.

Sheryl A Kingsberg, PhD
Tips for Taking a Sexual History

Hadine Joffe, MD, MSc
Sleep Disorders in Midlife

Steven R Goldstein, MD, FACOG, CCD, NCMP
Perimenopausal and Postmenopausal Bleeding

Lisa C Larkin, MD, FACP NCMP, IF
Adult Immunizations

Victor W Henderson, MD, MS, NCMP
Common Cognitive Complaints

Andrew M Kaunitz, MD, NCMP
Contraception in Perimenopause

Peter F Schnatz, DO, FACOG, FACP, NCMP
The Timing Hypothesis

NAMS is grateful to the following 2017 NAMS Corporate Liaison Council members for their grant funding that helped support the development of this series: Amag, Amgen, EndoCeutics, Pharmavite, and Sebela.

Copyright© 2022 |  Home  |  Privacy Policy  |   Site Map |


30050 Chagrin Blvd, Suite 120W - Pepper Pike, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 2 + 4.